A Pharmacokinetic study evaluating the pharmacokinetic parameters of different doses of Maxigesic® IV (intravenous paracetamol + intravenous ibuprofen) in healthy Japanese volunteers and Caucasian volunteers (ANZCTR) - Feb 2, 2024 - P1 | N=24 | Not yet recruiting | Sponsor: AFT Pharmaceuticals Ltd
New P1 trial
|